Cartalax
Also known as: Cartilage Peptide Bioregulator, Joint Bioregulator
A bioregulator peptide supporting cartilage health and joint function.
Overview
Cartalax is a synthetic tripeptide from the Khavinson bioregulator family designed to support cartilage and joint health. It may help maintain cartilage integrity and support joint function, particularly in aging or after injury.
Mechanism of Action
Gene regulatory effects on chondrocytes. Proposed to normalize cartilage matrix protein synthesis. May support collagen type II production and reduce degradation.
Pharmacokinetics
Small peptide allows oral/sublingual administration. Tissue-specific effects on cartilage.
Dosing Protocols
Note: These are research protocols from literature. This is not medical advice.
Joint Support
10-20 mg
1-2x daily
10-30 days
Repeat courses as needed
Stacking Recommendations
Peptides that may be combined based on complementary mechanisms in research settings.
Research Areas
Key Research Findings
- 1Improved joint function in osteoarthritis patients
- 2Support for cartilage matrix maintenance
- 3Gene expression effects on chondrocytes
- 4Reduced joint pain scores in studies
Side Effects & Contraindications
Reported Side Effects
- Generally well-tolerated
Contraindications
- None well-established
Safety Considerations
Generally well-tolerated. Limited Western clinical data. May be combined with other joint therapies.
Storage Requirements
Store at room temperature
Scientific References
- 1